Delivery Order SPE2DB24D9238-SPE2DB25FDQFX

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nucala 100 mg/ml auto-injectors, with a ceiling value of $3,785.80 and a period of performance through July 2, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,785.80, is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,785.80, is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract is valued at $3,785.80 and covers the delivery of Nucala 100 mg/mL auto-injector medication. The order is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,785.80 fixed-price contract is for the supply of Nucala 100 mg/mL auto-injectors, with a performance period through July 30, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which provides...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,464.50 delivery order is for the supply of Nucala 100 mg/mL auto-injectors, and is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows DLA to issue delivery orders for a wide range of...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $11,357.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nucala 100 mg/ml auto-injectors, with a period of performance ending on July 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 firm fixed-price contract is for the supply of Nucala 100 mg/mL auto-injectors, with a period of performance through August 29, 2024. This award is part of DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 contract is for the delivery of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB25FDQFX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order for the supply of Nucala 100 mg/mL auto-injectors, with a ceiling value of $3,785.80 and a period of performance ending on November 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.

Generated 2/14/25, 9:13 AM